A Swallow Instead of a Jab? A Capsule That Delivers Like an Injection In this episode, we’re joined by Karsten Lindhardt, Founder and CEO of  Biograil, to explore how a spring-loaded oral capsule could revolutionize drug delivery—offering patients a needle-free alternative with the same therapeutic impact as subcutaneous injections. From insulin to monoclonal antibodies, biologic drugs are typically delivered through injections—often multiple times a week. For many patients, this isn’t just painful; it disrupts daily life and can be a major barrier to long-term treatment compliance. Imagine a world where those same treatments could be taken as a pill—no injections, no anxiety, no need for clinical visits. That’s the vision behind Biograil’s BIONDD™ platform: a capsule that carries a mechanical device inside. Once swallowed, the capsule settles in the stomach, where it activates a spring-loaded insertion element like a bee’s stinger that delivers the active drug directly into the stomach lining. The result? Bioavailability comparable to injections, but with all the ease of an oral dose. Want to Know More? Join us in this conversation hosted by Martina Ribar Hestericová to hear how BioGrail is reshaping the future of biologic drug delivery—making it more convenient, less invasive, and better suited to real-life patient needs. We discuss everything from pediatric applications and veterinary uses to sustainability and the engineering behind this remarkable technology.